Cargando…
Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
Under the optimistic assumption of high-prophylactic HPV vaccine coverage, a significant reduction of cancer incidence can only be expected after decades. Thus, immune therapeutic strategies are needed for persistently infected individuals who do not benefit from the prophylactic vaccines. However,...
Autores principales: | Venuti, Aldo, Curzio, Gianfranca, Mariani, Luciano, Paolini, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554738/ https://www.ncbi.nlm.nih.gov/pubmed/26138695 http://dx.doi.org/10.1007/s00262-015-1734-0 |
Ejemplares similares
-
Mucosal Alpha-Papillomavirus (HPV89) in a rare skin lesion
por: Paolini, Francesca, et al.
Publicado: (2015) -
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
por: Rojas-Sepúlveda, Daniel, et al.
Publicado: (2018) -
Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers
por: Franconi, Rosella, et al.
Publicado: (2020) -
Opportunities for immunotherapy in microsatellite instable colorectal cancer
por: Westdorp, Harm, et al.
Publicado: (2016) -
Immune biological rationales for the design of combined radio- and immunotherapies
por: Hader, Michael, et al.
Publicado: (2020)